<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ABB</journal-id><journal-title-group><journal-title>Advances in Bioscience and Biotechnology</journal-title></journal-title-group><issn pub-type="epub">2156-8456</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/abb.2014.513116</article-id><article-id pub-id-type="publisher-id">ABB-51330</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Analgesic and Anti-Arthritic Effect of &lt;i&gt;Enicostemma littorale&lt;/i&gt; Blume
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>ohamed</surname><given-names>M. Shabi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Subashini</surname><given-names>Uthrapathy</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chellappan</surname><given-names>David Raj</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gayathri</surname><given-names>Krishnamoorthy</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dhevi</surname><given-names>Ravindhran</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jipnomon</surname><given-names>Joseph</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Victor</surname><given-names>G. Rajamanickam</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Department of Pharmacology, Amrita School of Pharmacy, Amrita Institute of Medical Science (AIMS), Amrita Vishwa Vidyapeetham University, Kochi, India</addr-line></aff><aff id="aff1"><addr-line>Department of Pharmacy, Asia Metropolitan University, Cheras, Malaysia</addr-line></aff><aff id="aff4"><addr-line>Centre for Research, Sairam Group of Institutions, Chennai, India</addr-line></aff><aff id="aff2"><addr-line>Centre for Advanced Research in Indian System of Medicine (CARISM), SASTRA University, Thanjavur, India</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>mohamedshabi@yahoo.co.in, shabi.mohamed@gmail.com(OMS)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>07</day><month>11</month><year>2014</year></pub-date><volume>05</volume><issue>13</issue><fpage>1018</fpage><lpage>1024</lpage><history><date date-type="received"><day>2</day>	<month>September</month>	<year>2014</year></date><date date-type="rev-recd"><day>12</day>	<month>October</month>	<year>2014</year>	</date><date date-type="accepted"><day>5</day>	<month>November</month>	<year>2014</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  <em>Enicostemma littorale</em> (Blume), the folk medicine is used for rheumatic pain and it was selected for scientific validation. The 85% methanolic extract obtained from the whole plant of 
  <em>Enicostemma littorale</em> has been assessed for analgesic and anti-inflammatory activity. The analgesic activity has been evaluated by hot plate and tail immersion method and the anti-inflammatory and antioxidant activities are evaluated by Complete Freund’s adjuvant induced arthritic model. The results of the evaluation of analgesic activity in hot plate and tail immersion method revealed that the extract exhibits significant activity at 150 mg/kg body weight and the effect is found to increase dose dependently. In Freund’s adjuvant induced arthritis, 
  <em>Enicostemma littorale</em> is found to decrease the paw volume (15.81%). Significant protection is also observed by elevating antioxidant enzymes. In conclusion, the 85% methanolic extract of 
  <em>Enicostemma littorale</em> possesses significant analgesic and anti-inflammatory activities in Freund’s adjuvant induced arthritic model in rats.
 
</p></abstract><kwd-group><kwd>Complete Freund’s Adjuvant</kwd><kwd> Hot Plate Oxidative Stress</kwd><kwd> Tail Immersion</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Rheumatoid arthritis (RA) is a chronic and systemic inflammatory disease of unknown etiology and is marked by synovial hyperplasia with local invasion of bone and cartilage leading to joint destruction [<xref ref-type="bibr" rid="scirp.51330-ref1">1</xref>] . RA affects ~1% of the adult population with more women being afflicted than men [<xref ref-type="bibr" rid="scirp.51330-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.51330-ref3">3</xref>] . Recent reports suggest that patients with RA not only have a higher chronic disease burden but also may have increased morbidity and mortality from cardiovascular disease compared with persons without RA [<xref ref-type="bibr" rid="scirp.51330-ref4">4</xref>] . However, despite optimal use of currently available anti-rheumatic agents, most RA patients live with chronic pain and severe functional decline because these therapies focus primarily on preventing joint inflammation and soft tissue swelling, but are not effective in preventing cartilage breakdown and the joint destruction associated with RA [<xref ref-type="bibr" rid="scirp.51330-ref5">5</xref>] . They also have undesirable side effects such as causing peptic ulcers [<xref ref-type="bibr" rid="scirp.51330-ref6">6</xref>] .</p><p>Herbal medicines have been described in traditional texts and used as antimicrobial, anti-inflammatory and antiviral medicine for the cure of allergies, RA, infections, wound healing and fever [<xref ref-type="bibr" rid="scirp.51330-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.51330-ref8">8</xref>] .</p><p>Enicostemma littorale Blume, (EL) a small herb of family Gentianaceae is commonly used by rural folks of Gujarat, India. It is cited in ancient literature as an anti-malarial, anti-pyretic and as a laxative [<xref ref-type="bibr" rid="scirp.51330-ref9">9</xref>] . Vasu et al. (2003) has confirmed the presence of phenols, tannins, flavonoids, glycosides, anthroquinones and sterols in EL and also reported its hypoglycemic, antioxidant and hypolipidemic potential in newly-diagnosed NIDDM patients [<xref ref-type="bibr" rid="scirp.51330-ref10">10</xref>] . The presence of alkaloid gentianine and the bitter glycoside swertiamarin in EL has been identified [<xref ref-type="bibr" rid="scirp.51330-ref11">11</xref>] . Recently aerial part of Enicostemma littorale is reported to show hypolipidemic effect in p-dimethylami- nobenzene (p-DAB) induced hepatotoxic animals [<xref ref-type="bibr" rid="scirp.51330-ref12">12</xref>] .</p><p>Sadique et al. (1987) have investigated the anti-inflammatory activity of Enicostemma littorale (EL) [<xref ref-type="bibr" rid="scirp.51330-ref13">13</xref>] . They have observed that 100 mg/100g body weight of EL’s alcoholic extract exhibits 54% anti-inflammatory activity in carrageenan induced paw edema. They have also evaluated the effect of the same extract in cotton pellet granuloma model. In our present study we have made an attempt to evaluate the analgesic, anti-inflam- matory and antioxidant activity of the 85% methanolic extract of EL. Analgesic activity is confirmed by hot plate and tail immersion method. Likewise we have performed pharmacological investigation on the anti-in- flammatory activity of EL using adjuvant induced animal models.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Plant Material</title><p>The Enicostemma littorale (EL) was collected from Madurai region, Tamilnadu, India. The plant was identified and authentified at Department of Pharmacognosy, Centre for Advanced Research in Indian System of Medicine, SASTRA University, Tamilnadu, India.</p></sec><sec id="s2_2"><title>2.2. Extraction</title><p>The material was dried in the shade. One kg of crushed root of the plant was extracted with seven liters of 85% methanol for 72 hours. The extraction was repeated for three times. The extract was concentrated by distillation. The final a trace of solvent was dried in a vacuum oven at 50˚C. The yield of extract was 3.34%.</p></sec><sec id="s2_3"><title>2.3. Animals</title><p>In this present study, six month old male Wistar albino rats weighing 180 - 210 g were used. The animals were obtained from Centre for Advanced Research in Indian System of Medicine (CARISM), SASTRA University, Tamilnadu, India were used. The rats were fed with standard laboratory chow and water before the experiment. The animal house was equipped with temperature 22˚C &#177; 1˚C at 14/10 h light/dark cycle. All the animal testing was performed after getting clearance from Institutional Animal ethical committee (Clearance No. 11/SASTRA/ IAEC/RPP).</p></sec><sec id="s2_4"><title>2.4. Experimental Protocol for Hot Plate Test</title><p>In the hot plate test [<xref ref-type="bibr" rid="scirp.51330-ref14">14</xref>] , rats were divided into different groups. Each group consists of six animals. Group 1 animals were treated with 5% Tween 80 in water, Group 2 animals were treated with extract at the dose of 150 mg/kg body weight. Group 3 animals were treated with extract at the dose of 250 mg/kg body weight. Group 4 animals were treated with extract at the dose of 350 mg/kg body weight. All groups of animal received the single dose of extract 30 min prior of nociceptive stimulation. In this test, animals were individually placed on a hot plate maintained at a constant temperature (55˚C &#177; 0.3˚C). The latency to first sign of hind paw licking or jump response to avoid heat nociception was taken as an index of nociceptive threshold with cut off time of 15 sec. The nociceptive threshold was observed at 1, 2, 3 and 4 hours after wit treatment with EL and the vehicle.</p></sec><sec id="s2_5"><title>2.5. Experimental Protocol for Tail Immersion Method</title><p>In the tail immersion method [<xref ref-type="bibr" rid="scirp.51330-ref15">15</xref>] , rats were divided into different groups. Each group consists of six animals. Group 1 animals were treated with 5% Tween 80 in water, Group 2 animals were treated with extract at the dose of 150 mg/kg body weight. Group 3 animals were treated with extract at the dose of 250 mg/kg body weight. Group 4 animals were treated with extract at the dose of 350 mg/kg body weight. All groups of animal received the single dose of extract 30 min prior of nociceptive stimulation. The anti-nociceptive effect was determined in rats using the tail-flick test by analgesiometer. The responses were elicited at 15, 30, 45 and 60 min after treatment with EL and the vehicle.</p></sec><sec id="s2_6"><title>2.6. Experimental Protocol for Freund’s Adjuvant Induced Arthritis</title><p>Animals were divided in to three groups. Each group consists of six animals. Group 1 animals were treated with 5% Tween 80 in water, Group 2 animals were administered with Complete Freund’s adjuvant (CFA), Groups 3 animals were treated with extract at the dose of 150 mg/kg body weight and CFA. The right foot pad of each rat was injected subcutaneously with single dose of 0.05 ml of CFA with emulsified in an equal volume of phosphate buffered saline [<xref ref-type="bibr" rid="scirp.51330-ref16">16</xref>] . The animals were treated with extract once a day for the period of 45 days. On 46<sup>th</sup> day all the animals were sacrificed by cervical dislocation under ether anesthesia. Liver and kidney was excised from animals and washed with saline. 10% tissue homogenate was prepared in Tris buffer and various biochemical parameters like thio barbituric acid reactive substances (TBARS) [<xref ref-type="bibr" rid="scirp.51330-ref17">17</xref>] , reduced glutathione (GSH) [<xref ref-type="bibr" rid="scirp.51330-ref18">18</xref>] , glutathione peroxidase (GPx) [<xref ref-type="bibr" rid="scirp.51330-ref19">19</xref>] and catalase [<xref ref-type="bibr" rid="scirp.51330-ref20">20</xref>] were estimated.</p></sec><sec id="s2_7"><title>2.7. Statistical Analysis</title><p>The values were expressed as Mean &#177; SD. Significant difference have been observed using One Way Analysis of variance (ANOVA) by SPSS software version 12.0. p &lt; 0.05, was considered as significant difference. Groups having different alphabets are differ significantly at p &lt; 0.05.</p></sec></sec><sec id="s3"><title>3. Results</title><p>On treating animals with EL (150 mg/kg body weight.) significant differences have been observed in the 1<sup>st</sup> hour itself and maximum effect has been observed in the 2<sup>nd</sup> hour which has extended up to 3<sup>rd</sup> hour. Enhancing the dose of extract one can increase the effect and maximum effect has been observed 1<sup>st</sup> hour at 250 and 350 mg/kg body weight of extract (<xref ref-type="table" rid="table1">Table 1</xref>). Likewise treating animals with EL extract increased the response time significantly (p &lt; 0.05) at 15 minutes itself. Significant increment in response time has not been observed along with the dose of the extract (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>From <xref ref-type="table" rid="table3">Table 3</xref>, the paw volume of CFA administered and EL treated animals. The paw volume is found to be decreased from the 22<sup>nd</sup> day onwards and EL decreased the paw volume by 15.81% at the end of 45<sup>th</sup> day (<xref ref-type="table" rid="table3">Table 3</xref>).</p><p>Administration of Complete Freund’s adjuvant causes an increased level of TBARS in liver tissue and not in the kidney in diseased animals (p &lt; 0.05, <xref ref-type="table" rid="table4">Table 4</xref>). Treatment of animals with EL significantly decreased the TBARS by p &lt; 0.05 in liver tissue. Likewise, catalase level is observed to be decreased in the liver tissue and not in the kidney in treated group. EL treatment increased the level of catalase (<xref ref-type="table" rid="table4">Table 4</xref>).</p><p><xref ref-type="table" rid="table5">Table 5</xref> shows the level of glutathione and its dependent enzyme in both liver and kidney homogenate. Administration of Complete Freund’s adjuvant brings the deletion of both glutathione and glutathione peroxidase in liver tissue, whereas, significant depletion has not been observed in kidney tissue (p &lt; 0.05). Treating animals with EL shows a rise in the level of both glutathione and its enzyme significantly (p &lt; 0.05, <xref ref-type="table" rid="table5">Table 5</xref>).</p></sec><sec id="s4"><title>4. Discussion</title><p>Rheumatoid arthritis is an autoimmune disease characterized by chronic inflammation, hyperproliferation of the synovial lining and cartilage destruction [<xref ref-type="bibr" rid="scirp.51330-ref21">21</xref>] . EL treatment is observed to increase the response time significantly in both hot plate and tail immersion method (p &lt; 0.05). The elevated pain threshold of rats towards heat</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Analgesic activity of Enicostemma littorale on rats in hot plate method</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Groups</th><th align="center" valign="middle" >Dose</th><th align="center" valign="middle"  colspan="5"  >Response time in sec</th></tr></thead><tr><td align="center" valign="middle" >Reaction time in h</td><td align="center" valign="middle" >0 h</td><td align="center" valign="middle" >1 h</td><td align="center" valign="middle" >2 h</td><td align="center" valign="middle" >3 h</td><td align="center" valign="middle" >4 h</td></tr><tr><td align="center" valign="middle" >Group 1</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >3.1 &#177; 0.90</td><td align="center" valign="middle" >3.1 &#177; 1.50</td><td align="center" valign="middle" >3.8 &#177; 0.96</td><td align="center" valign="middle" >3.1 &#177; 0.30</td><td align="center" valign="middle" >4.8 &#177; 0.50<sup>*</sup></td></tr><tr><td align="center" valign="middle" >Group 2</td><td align="center" valign="middle" >MLE 150 mg/kg</td><td align="center" valign="middle" >2.5 &#177; 0.0<sup>*</sup></td><td align="center" valign="middle" >4.3 &#177; 1.20<sup>*</sup></td><td align="center" valign="middle" >5.0 &#177; 0.8<sup>*</sup></td><td align="center" valign="middle" >5.3 &#177; 2.2<sup>*</sup></td><td align="center" valign="middle" ><sup> </sup></td></tr><tr><td align="center" valign="middle" >Group 3</td><td align="center" valign="middle" >MLE 250 mg/kg</td><td align="center" valign="middle" >2.4 &#177; 0.50<sup>*</sup></td><td align="center" valign="middle" >8.12 &#177; 0.90<sup>*</sup><sup>c</sup></td><td align="center" valign="middle" >7.5 &#177; 0.60<sup>*</sup></td><td align="center" valign="middle" >8.3 &#177; 1.50<sup>*</sup></td><td align="center" valign="middle" >4.3 &#177; 1.20<sup>*</sup></td></tr><tr><td align="center" valign="middle" >Group 4</td><td align="center" valign="middle" >MLE 350 mg/kg</td><td align="center" valign="middle" >2.8 &#177; 0.6<sup>*</sup></td><td align="center" valign="middle" >8.4 &#177; 2.80<sup>*</sup></td><td align="center" valign="middle" >6.0 &#177; 1.60<sup>*</sup></td><td align="center" valign="middle" >8.1 &#177; 1.80<sup>*</sup></td><td align="center" valign="middle" >4.5 &#177; 1.70<sup>*</sup></td></tr></tbody></table></table-wrap><p>Values are Mean &#177; SD. One Way ANOVA was carried out using SPSS software version 12.0. Significant difference (<sup>*</sup>p &lt; 0.05) has been observed between 0 hour and different hours of the same group.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Analgesic activity of Enicostemma littorale on rats in tail immersion method</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Drug</th><th align="center" valign="middle" >Dose</th><th align="center" valign="middle"  colspan="5"  >Response time in sec</th></tr></thead><tr><td align="center" valign="middle" >Reaction time in min</td><td align="center" valign="middle" >0 min</td><td align="center" valign="middle" >15 min</td><td align="center" valign="middle" >30 min</td><td align="center" valign="middle" >45 min</td><td align="center" valign="middle" >60 min</td></tr><tr><td align="center" valign="middle" >Group 1</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >4.3 &#177; 0.50</td><td align="center" valign="middle" >4.0 &#177; 0.80</td><td align="center" valign="middle" >3.8 &#177; 0.50</td><td align="center" valign="middle" >5.3 &#177; 0.96</td><td align="center" valign="middle" >4.0 &#177; 0.80</td></tr><tr><td align="center" valign="middle" >Group 2</td><td align="center" valign="middle" >MLE 150 mg/kg</td><td align="center" valign="middle" >2.8 &#177; 0.50<sup>*</sup></td><td align="center" valign="middle" >4.3 &#177; 0.50<sup>*</sup></td><td align="center" valign="middle" >3.5 &#177; 1.00<sup>*</sup></td><td align="center" valign="middle" >4.3 &#177; 0.96<sup>*</sup></td><td align="center" valign="middle" >4.9 &#177; 0.90<sup>*</sup></td></tr><tr><td align="center" valign="middle" >Group 3</td><td align="center" valign="middle" >MLE 250 mg/kg</td><td align="center" valign="middle" >2.6 &#177; 0.50<sup>*</sup></td><td align="center" valign="middle" >3.5 &#177; 1.00<sup>*</sup></td><td align="center" valign="middle" >4.8 &#177; 1.30<sup>*</sup></td><td align="center" valign="middle" >4.1 &#177; 0.90<sup>*</sup></td><td align="center" valign="middle" >4.0 &#177; 0.01<sup>*</sup></td></tr><tr><td align="center" valign="middle" >Group 4</td><td align="center" valign="middle" >MLE 350 mg/kg</td><td align="center" valign="middle" >3.1 &#177; 0.30<sup>*</sup></td><td align="center" valign="middle" >4.3 &#177; 0.50<sup>*</sup></td><td align="center" valign="middle" >4.0 &#177; 0.80<sup>*</sup></td><td align="center" valign="middle" >4.4 &#177; 1.10<sup>*</sup></td><td align="center" valign="middle" >4.1 &#177; 0.90<sup>*</sup></td></tr></tbody></table></table-wrap><p>Values are Mean &#177; SD. One Way ANOVA was carried out using SPSS software version 12.0. Significant difference (<sup>*</sup>p &lt; 0.05) has been observed between 0 hour and different hours of the same group.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Changes in paw volume of Complete Freund’s adjuvant induced arthritic rats treated with Enicostemma littorale</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Days</th><th align="center" valign="middle" >Diseased Animals</th><th align="center" valign="middle"  colspan="2"  >Enicostemma littorale (150 mg/kg, B.wt)</th></tr></thead><tr><td align="center" valign="middle" >P.V</td><td align="center" valign="middle" >P.V</td><td align="center" valign="middle" >P.I</td></tr><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >4.27 &#177; 0.08</td><td align="center" valign="middle" >4.1 &#177; 0.01</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >6.3 &#177; 0.43</td><td align="center" valign="middle" >7.07 &#177; 0.25</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >15</td><td align="center" valign="middle" >6.68 &#177; 0.51</td><td align="center" valign="middle" >6.78 &#177; 0.38</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >22</td><td align="center" valign="middle" >6.7 &#177; 0.87</td><td align="center" valign="middle" >6.42 &#177; 0.26</td><td align="center" valign="middle" >4.18</td></tr><tr><td align="center" valign="middle" >29</td><td align="center" valign="middle" >6.7 &#177; 0.46</td><td align="center" valign="middle" >6.08 &#177; 0.15</td><td align="center" valign="middle" >9.25</td></tr><tr><td align="center" valign="middle" >36</td><td align="center" valign="middle" >6.63 &#177; 0.32</td><td align="center" valign="middle" >5.9 &#177; 0.2<sup>*</sup></td><td align="center" valign="middle" >11.01</td></tr><tr><td align="center" valign="middle" >43</td><td align="center" valign="middle" >6.45 &#177; 0.39</td><td align="center" valign="middle" >5.43 &#177; 0.07<sup>*</sup></td><td align="center" valign="middle" >15.81</td></tr></tbody></table></table-wrap><p>Note: P.V—Paw volume in mm; P.I—Percentage Inhibition as compared to Control; Values are Mean &#177; SD. <sup>*</sup>p &lt; 0.05 was considered statically significant.</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Antioxidant effect of Enicostemma littorale in adjuvant administered rats</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Groups</th><th align="center" valign="middle"  colspan="2"  >TABRS</th><th align="center" valign="middle"  colspan="2"  >Catalase</th></tr></thead><tr><td align="center" valign="middle" >Liver</td><td align="center" valign="middle" >Kidney</td><td align="center" valign="middle" >Liver</td><td align="center" valign="middle" >Kidney</td></tr><tr><td align="center" valign="middle" >Group 1</td><td align="center" valign="middle" >0.47 &#177; 0.05</td><td align="center" valign="middle" >0.29 &#177; 0.04</td><td align="center" valign="middle" >17.60 &#177; 1.59</td><td align="center" valign="middle" >15.24 &#177; 1.81</td></tr><tr><td align="center" valign="middle" >Group 2</td><td align="center" valign="middle" >0.82 &#177; 0.03<sup>*b</sup></td><td align="center" valign="middle" >0.34 &#177; 0.03<sup>ns</sup></td><td align="center" valign="middle" >11.23 &#177; 0.72<sup>*a</sup></td><td align="center" valign="middle" >12.49 &#177; 0.56<sup>ns</sup></td></tr><tr><td align="center" valign="middle" >Group 3</td><td align="center" valign="middle" >0.64 &#177; 0.22<sup>a</sup></td><td align="center" valign="middle" >0.32 &#177; 0.07<sup>ns</sup></td><td align="center" valign="middle" >17.52 &#177; 1.37<sup>b</sup></td><td align="center" valign="middle" >12.36 &#177; 1.01<sup>ns</sup></td></tr></tbody></table></table-wrap><p>Values are Mean &#177; SD; <sup>*</sup>Refers to significant difference between Group 1 and 2 (p &lt; 0.05); <sup>ns</sup>No significant difference; <sup>a,b</sup>Significant difference between Group 2 vs Group 3 and 4.</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Effect of Enicostemma littorale on Glutathione and its related enzyme in adjuvant administered rats</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Groups</th><th align="center" valign="middle"  colspan="2"  >Glutathione peroxidase</th><th align="center" valign="middle"  colspan="2"  >Reduced glutathione</th></tr></thead><tr><td align="center" valign="middle" >Liver</td><td align="center" valign="middle" >Kidney</td><td align="center" valign="middle" >Liver</td><td align="center" valign="middle" >Kidney</td></tr><tr><td align="center" valign="middle" >Group 1</td><td align="center" valign="middle" >0.1863 &#177; 0.0007</td><td align="center" valign="middle" >0.1122 &#177; 0.0001</td><td align="center" valign="middle" >25.85 &#177; 0.39</td><td align="center" valign="middle" >26.67 &#177; 2.65</td></tr><tr><td align="center" valign="middle" >Group 2</td><td align="center" valign="middle" >0.1068 &#177; 0.0001<sup>*a</sup></td><td align="center" valign="middle" >0.1124 &#177; 0.0001<sup>ns</sup></td><td align="center" valign="middle" >19.74 &#177; 2.45<sup>*a</sup></td><td align="center" valign="middle" >25.72 &#177; 3.99<sup>ns</sup></td></tr><tr><td align="center" valign="middle" >Group 3</td><td align="center" valign="middle" >0.1358 &#177; 0.0005<sup>b</sup></td><td align="center" valign="middle" >0.1056 &#177; 0.0012<sup>ns</sup></td><td align="center" valign="middle" >26.20 &#177; 3.37<sup>b</sup></td><td align="center" valign="middle" >25.25 &#177; 0.36<sup>ns</sup></td></tr></tbody></table></table-wrap><p>Values are Mean &#177; SD; <sup>*</sup>Refers to significant difference between Group 1 and 2 (p &lt; 0.05); <sup>ns</sup>No significant difference;<sup> </sup><sup>a,b</sup>Significant difference between Group 2 vs Group 3 and 4.</p><p>might be due to the centrally acting effect. The flavonoids present in the EL might be responsible for this analgesic activity [<xref ref-type="bibr" rid="scirp.51330-ref22">22</xref>] .</p><p>However, some of the earlier reports indicating that inflammation and tissue injury related oxidative stress have been implicated in the pathogenesis of rheumatoid arthritis. Free radicals are enormously produced at the site of inflammation and tissue injuries. Excessive generation of reactive oxygen species (ROS) leads to a variety of pathological processes such as inflammation, diabetes, hepatic damage and cancer [<xref ref-type="bibr" rid="scirp.51330-ref23">23</xref>] .</p><p>TBARS level of disease animals increased significantly (p &lt; 0.05). Free radicals, the highly reactive entity and very short lived molecules, are constantly produced in a wide variety of normal physiological functions. Although free radicals perform some useful functions, they are toxic when generated in excess [<xref ref-type="bibr" rid="scirp.51330-ref24">24</xref>] . The most important characteristic of toxic free radicals generated by CFA administration in either in vivo or in vitro is peroxidation of lipids resulting in tissue damage and death of affected cells [<xref ref-type="bibr" rid="scirp.51330-ref25">25</xref>] . The profound body of evidence implicating that free radical induced lipid peroxidation in the pathogenesis of various pathological conditions including chronic inflammatory conditions [<xref ref-type="bibr" rid="scirp.51330-ref26">26</xref>] .</p><p>The harmful effect of ROS is neutralized by a broad class of protective agents termed antioxidants which prevents oxidative damage by reacting with free radicals before any other molecules can become a target. The free radical mediated damage is prevented by various enzymatic antioxidants like catalase, glutathione peroxidase and non-enzymatic antioxidants like reduced glutathione [<xref ref-type="bibr" rid="scirp.51330-ref27">27</xref>] .</p><p>Glutathione peroxidase prevents the accumulation of oxidized lipids in mitochondrial cell membranes and also detoxifies H<sub>2</sub>O<sub>2</sub> by utilizing reduced glutathione as a co-substrate [<xref ref-type="bibr" rid="scirp.51330-ref28">28</xref>] (Hassan et al., 2001). The glutathi- one and glutathione peroxidase levels of CFA administered animals were observed to have a decrease in diseased animals (p &lt; 0.05).</p><p>The antioxidant activity of EL might be due to the presence of flavonoids compounds. Flavonoids have been reported to have anti-inflammatory, anti-arthritic activity [<xref ref-type="bibr" rid="scirp.51330-ref29">29</xref>] . The present study establishes the therapeutic rationale of using EL extract in various anti-inflammatory polyherbal formulations. Anti-inflammatory effect in chronic model with EL could be because of one of its constituents i.e. Betulin, a triterpene sapogenin that is known to have anti-inflammatory activity [<xref ref-type="bibr" rid="scirp.51330-ref30">30</xref>] . The antioxidant and anti-inflammatory activities of EL might be due to the presence of swertimarin.</p></sec><sec id="s5"><title>5. Conclusion</title><p>In conclusion, Enicostemma littorale increased the response time of animals in both hot plate and tail immersion method. EL increased the antioxidants thereby decreases the oxidative stress. The decreased oxidative stress is associated with a decreased paw volume. Thus, the Enicostemma littorale is a potent analgesic, anti-inflamma- tory and antioxidant herb.</p></sec><sec id="s6"><title>Acknowledgements</title><p>One of the author Mr. Mohamed Shabi is thank to Vice chancellor, SASTRA University, who made a great support to this research and Division of Drugs and Pharmaceutical, Department of Science and Technology, Government of India for providing the fund to complete the work successfully.</p></sec><sec id="s7"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.51330-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Firestein, G.S. (1992) Mechanisms of Tissue Destruction and Cellular Activation in Rheumatoid Arthritis. Current Opinion in Rheumatology, 4, 348-354. http://dx.doi.org/10.1097/00002281-199206000-00012</mixed-citation></ref><ref id="scirp.51330-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Lawrence, R.C., et al. (1998) Estimates of the Prevalence of Arthritis and Selected Musculoskeletal Disorders in the United States. Arthritis Rheumatology, 41, 778-799. http://dx.doi.org/10.1002/1529-0131(199805)41:5&lt;778::AID-ART4&gt;3.0.CO;2-V</mixed-citation></ref><ref id="scirp.51330-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Gabriel, S.E. (2001) The Epidemiology of Rheumatoid Arthritis. Rheumatic Disease Clinics of North America, 27, 269-281. http://dx.doi.org/10.1016/S0889-857X(05)70201-5</mixed-citation></ref><ref id="scirp.51330-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Maradit-Kremers, H., Nicola, P.J., Crowson, C.S., Ballman, K.V. and Gabriel, S.E. (2005) Cardiovascular Death in Rheumatoid Arthritis: A Population-Based Study. Arthritis Rheumatology, 52, 722-732. http://dx.doi.org/10.1002/art.20878</mixed-citation></ref><ref id="scirp.51330-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Feldman, M. and Steinman, L. (2005) Design of Effective Immunotherapy for Human Autoimmunity. Nature, 435, 612-619. http://dx.doi.org/10.1038/nature03727</mixed-citation></ref><ref id="scirp.51330-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Corley, D.A., Kerlikowske, K., Verma, R. and Buffler, P. (2003) Protective Association of Aspirin/NSAIDs and Esophageal Cancer: A Systematic Review and Meta-Analysis. Gastroenterology, 124, 47-56. http://dx.doi.org/10.1053/gast.2003.50008</mixed-citation></ref><ref id="scirp.51330-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Borchers, A.T., Keen, C.L., Stern, J.S. and Gershwin, M.E. (2000) Inflammation and Native American Medicine: The Role of Botanicals. The American Journal of Clinical Nutrition, 72, 339-347.</mixed-citation></ref><ref id="scirp.51330-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Brune, K. (2004) Safety of Anti-Inflammatory Treatment—New Ways of Thinking. Rheumatology (Oxford), 43S, 16-20. http://dx.doi.org/10.1093/rheumatology/keh104</mixed-citation></ref><ref id="scirp.51330-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Vyas, D.S., Sharma, V.N., Sharma, H.K. and Khanna, N.K. (1979) Preliminary Study of Antidiabetic Properties of Aegle marmelos and Enicostemma littorale. Indian Journal of Medical Research, 14, 2-4.</mixed-citation></ref><ref id="scirp.51330-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Vasu, V.T., Ashwinikumar, C., Maroo, J. and Gupta S. (2003) Antidiabetic Effect of Enicostemma littorale Blume Aqueous Extract in Newly Diagnosed Non-Insulin-Dependent Diabetes Mellitus Patients (NIDDM): A Preliminary Investigation. Oriental Pharmacy and Experimental Medicine, 3, 84-89. http://dx.doi.org/10.3742/OPEM.2003.3.2.084</mixed-citation></ref><ref id="scirp.51330-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Vishwakarma, S.L., Rajani, M., Bagul, M.S. and Goyal, R.K. (2004) A Rapid Method for the Isolation of Swertiamarin from Enicostemma littorale. Pharmaceutical Biology, 42, 400-403. http://dx.doi.org/10.1080/13880200490885095</mixed-citation></ref><ref id="scirp.51330-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Gopal, R., Gnanamani, A., Udayakumar, R. and Sadulla, S. (2004) Enicostemma littorale Blume—A Potential Hypolipidemic Plant. Indian Journal of Natural Products and Resources, 3, 401-405.</mixed-citation></ref><ref id="scirp.51330-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Sadique, J., Chandra, T., Thenmozhi, V. and Elango, V. (1987) The Anti-Inflammatory Activity of Enicostemma littorale and Mullogo cerviana. Biochemical Medicine and Metabolic Biology, 37, 167-176. http://dx.doi.org/10.1016/0885-4505(87)90023-5</mixed-citation></ref><ref id="scirp.51330-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Eddy, N.B. and Leimbach, D. (1953) Synthetic Analgesics II. Dithienylbutenyl and Dithienylbutylamines. Journal of Pharmacology and Experimental Therapeutics, 107, 385-393.</mixed-citation></ref><ref id="scirp.51330-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Di Stasi, L.C., Costa, M., Menda&amp;ccedilolli, S.L.J., Kirizawa, M., Gomes, C. and Trolin, G. (1988) Screening in Mice of Some Medicinal Plants Used for Analgesic Purposes in the State of Sao Paulo. Journal of Ethnopharmacology, 24, 205-211. http://dx.doi.org/10.1016/0378-8741(88)90153-5</mixed-citation></ref><ref id="scirp.51330-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Pearson, C.M. (1972) Arthritis in Animals. In: Arthritis and Allied Conditions, 8th Edition, Lea and Febiger, Philadelphia, 5-15.</mixed-citation></ref><ref id="scirp.51330-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Okhawa, H., Ohishi, N. and Yagi, K. (1979) Assay for Lipid Peroxides in Animal Tissues by Thiobarbituric Acid Reaction. Analytical Biochemistry, 95, 351-358. http://dx.doi.org/10.1016/0003-2697(79)90738-3</mixed-citation></ref><ref id="scirp.51330-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Ellman, G.L. (1959) Tissue Sulfhydryl Groups. Archives of Biochemistry and Biophysics, 82, 70-77. http://dx.doi.org/10.1016/0003-9861(59)90090-6</mixed-citation></ref><ref id="scirp.51330-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Rotruck, J.T., Pope, A.L., Ganther, H.E., Swanson, A.B., Hafeman, D.G. and Hoekstra, W.G. (1973) Selenium: Biochemical Role as a Component of Glutathione Peroxidase. Science, 179, 588-590. http://dx.doi.org/10.1126/science.179.4073.588</mixed-citation></ref><ref id="scirp.51330-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Sinha, A.K. (1972) Colorimetric Assay of Catalase. Analytical Biochemistry, 47, 389-394. http://dx.doi.org/10.1016/0003-2697(72)90132-7</mixed-citation></ref><ref id="scirp.51330-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Schiff, M. (1997) Emerging Treatments for Rheumatoid Arthritis. American Journal of Medicine, 102, 11-15. http://dx.doi.org/10.1016/S0002-9343(97)00411-7</mixed-citation></ref><ref id="scirp.51330-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Ramaswamy, S., Pillai, N.P., Gopalakrishnan, V., Parmar, N.S. and Ghosh, M.N. (1985) Analgesic Effect of O-(β-Hydroxyl ethyl) Rutoside in Mice. Indian Journal of Experimental Biology, 23, 219-220.</mixed-citation></ref><ref id="scirp.51330-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Gulcin, I., Buyukokuroglu, M.E., Oktay, M. and Kufrevioglu, O.I. (2002) On the in Vitro Antioxidant Properties of Melatonin. Journal of Pineal Research, 33, 167-171. http://dx.doi.org/10.1034/j.1600-079X.2002.20920.x</mixed-citation></ref><ref id="scirp.51330-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Parke, D.V. and Sapota, A. (1996) Chemical Toxicity and Reactive Oxygen Species. International Journal of Occupational Medicine and Environmental Health, 9, 331-340.</mixed-citation></ref><ref id="scirp.51330-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Bandyopadhyay, U., Das, D. and Banerjee, R.K. (1999) Reactive Oxygen Species: Oxidative Damage and Pathogenesis. Current Science, 77, 658-666.</mixed-citation></ref><ref id="scirp.51330-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Halliwell, B. (1994) Free Radicals, Antioxidants and Human Disease: Curiosity, Causes or Consequences? Lancet, 344, 721-724. http://dx.doi.org/10.1016/S0140-6736(94)92211-X</mixed-citation></ref><ref id="scirp.51330-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Ray, G. and Husain, S.A. (2002) Oxidants, Antioxidants and Carcinogenesis. Indian Journal of Experimental Biology, 40, 1213-1232.</mixed-citation></ref><ref id="scirp.51330-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Hassan, M.Q., Hadi, R.A., A1-RawI, Z.S., Padron, V.A. and Stohs, S.J. (2001) The Glutathione Defense System in the Pathogensis of Rheumatoid Arthritis. Journal of Applied Toxicology, 21, 69-73. http://dx.doi.org/10.1002/jat.736</mixed-citation></ref><ref id="scirp.51330-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Li, D.W., Lee, E.B., Kang, S.S., Hyun, J.E. and Whang, W.K. (2002) Activity Guided Isolation of Saponins from Kalopanax pictus with Anti-Inflammatory Activity. Chemical and Pharmaceutical Bulletin, 50, 900-903. http://dx.doi.org/10.1248/cpb.50.900</mixed-citation></ref><ref id="scirp.51330-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Rai, J. and Thakar, K.A. (1966) Chemical Investigation of E. littorale Blume. Current Science, 35, 148-149.</mixed-citation></ref></ref-list></back></article>